Found: 27
Select item for more details and to access through your institution.
Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.943574
- By:
- Publication type:
- Article
Effects of ageing and frailty on circulating monocyte and dendritic cell subsets.
- Published in:
- NPJ Aging, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41514-024-00144-6
- By:
- Publication type:
- Article
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4958, doi. 10.3390/jcm10214958
- By:
- Publication type:
- Article
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01981
- By:
- Publication type:
- Article
Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01638
- By:
- Publication type:
- Article
Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1201575
- By:
- Publication type:
- Article
Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1202160
- By:
- Publication type:
- Article
Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1197293
- By:
- Publication type:
- Article
Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 9, p. 1322, doi. 10.1002/acr.25354
- By:
- Publication type:
- Article
Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 1, p. 105, doi. 10.1002/acr.25173
- By:
- Publication type:
- Article
Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. e45, doi. 10.1093/rheumatology/kead435
- By:
- Publication type:
- Article
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 7, p. 3060, doi. 10.1093/rheumatology/keab814
- By:
- Publication type:
- Article
Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 1072, doi. 10.1093/rheumatology/keab483
- By:
- Publication type:
- Article
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica.
- Published in:
- Rheumatology, 2020, v. 59, n. 1, p. 176, doi. 10.1093/rheumatology/kez261
- By:
- Publication type:
- Article
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 8, p. 1383, doi. 10.1093/rheumatology/kez034
- By:
- Publication type:
- Article
303. Leukocyte dynamics before, during and after treatment in giant cell arteritis and polymyalgia rheumatic patients.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
194. Distribution of macrophage subsets in temporal artery biopsies of patients with giant cell arteritis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
055. High Serum Angiopoietin-2 Levels Identify Large Vessel Inflammation in Patients with Polymyalgia Rheumatica.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
042. Profiling the Autoantibody Repertoire in Vasculitis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Frailty is related to serum inflammageing markers: results from the VITAL study.
- Published in:
- Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00391-3
- By:
- Publication type:
- Article
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1366, doi. 10.1002/art.40520
- By:
- Publication type:
- Article
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447555
- By:
- Publication type:
- Article
Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50760-9
- By:
- Publication type:
- Article
Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1812, doi. 10.1002/art.42525
- By:
- Publication type:
- Article
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 12, p. 2327, doi. 10.1002/art.41887
- By:
- Publication type:
- Article
Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02754-5
- By:
- Publication type:
- Article